Zheng W - Search Results

1

Aggressive behavior and elevated lactate dehydrogenase at baseline confer inferior prognosis in patients with primary cutaneous lymphoma.

Liu WP, Song YQ, Zheng W, Wang XP, Ding N, Zhu J. Liu WP, et al. Among authors: zheng w. Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):534-40. doi: 10.1016/j.clml.2013.04.011. Epub 2013 Jun 10. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23763922

2

L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma.

Yong W, Zheng W, Zhang Y, Zhu J, Wei Y, Zhu D, Li J. Yong W, et al. Among authors: zheng w. Int J Hematol. 2003 Aug;78(2):163-7. doi: 10.1007/BF02983387. Int J Hematol. 2003. PMID: 12953813 Clinical Trial.

3

[Clinical analysis of liver non-Hodgkin's lymphoma].

Zheng W, Yong WB, Zhu J, Zhang YT, Wang XP, Xie Y. Zheng W, et al. Ai Zheng. 2004 Nov;23(11 Suppl):1451-4. Ai Zheng. 2004. PMID: 15566655 Chinese.

4

[Clinical characteristics and prognosis of diffuse large B-cell lymphoma].

Yang BY, Yong WB, Zhu J, Zheng W, Zhang YT, Wang XP, Meng SN. Yang BY, et al. Among authors: zheng w. Zhonghua Zhong Liu Za Zhi. 2005 Mar;27(3):174-6. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15946571 Chinese.

5

Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.

Yong W, Zheng W, Zhu J, Zhang Y, Wei Y, Wang X, Lin N, Xie Y, Xu B, Li J. Yong W, et al. Among authors: zheng w. Hematol Oncol. 2006 Mar;24(1):28-32. doi: 10.1002/hon.765. Hematol Oncol. 2006. PMID: 16323259

6

[Interleukin-2 improves the antitumor activity of Rituximab in patients with B-cell lymphoma in vitro].

Zhang WX, Guo J, Lin BH, Meng SN, Wang XP, Xie Y, Zheng W, Zhang YT, Zhu J. Zhang WX, et al. Among authors: zheng w. Zhonghua Xue Ye Xue Za Zhi. 2007 Jan;28(1):41-4. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 17649726 Chinese.

7

L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type.

Yong W, Zheng W, Zhu J, Zhang Y, Wang X, Xie Y, Lin N, Xu B, Lu A, Li J. Yong W, et al. Among authors: zheng w. Ann Hematol. 2009 Jul;88(7):647-52. doi: 10.1007/s00277-008-0669-3. Epub 2008 Dec 24. Ann Hematol. 2009. PMID: 19107482

8

[Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].

Zheng W, Zhu J, Xie Y. Zheng W, et al. Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):875-6. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173838 Chinese. No abstract available.

9

[Autologous regulatory T cells can suppress the proliferation of lymphoma cell line in vitro].

Ying ZT, Guo J, Ren J, Kong Y, Yuan ZH, Liu XJ, Zhang C, Zheng W, Song YQ, Zhang YT, Zhu J. Ying ZT, et al. Among authors: zheng w. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):583-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19549368 Chinese.

10

[Regulatory T cells inhibit proliferation of mouse lymphoma cell line EL4 in vitro].

Zhang C, Kong Y, Guo J, Ying ZT, Yuan ZH, Zhang YT, Zheng W, Song YQ, Li PP, Zhu J. Zhang C, et al. Among authors: zheng w. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1198-203. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 21129260 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,918 results

Search Page

Filters